Journal of Andrology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published-Ahead-of-Print May 28, 2009, DOI:10.2164/jandrol.108.007278
Journal of Andrology, Vol. 30, No. 6, November/December 2009
Copyright © American Society of Andrology
DOI: 10.2164/jandrol.108.007278

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
30/6/679    most recent
Author Manuscript (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Efesoy, O.
Right arrow Articles by Akbay, E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Efesoy, O.
Right arrow Articles by Akbay, E.

The Efficacy of Recombinant Human Follicle-Stimulating Hormone in the Treatment of Various Types of Male-Factor Infertility at a Single University Hospital

OZAN EFESOY, SELAHITTIN ÇAYAN AND ERDEM AKBAY

From the Department of Urology, University of Mersin School of Medicine, Mersin, Turkey.

Correspondence to: Dr Selahittin Çayan, Associate Professor of Urology, University of Mersin School of Medicine, Department of Urology, 33079-Mersin, Turkey (e-mail: selcayan{at}mersin.edu.tr).



Abstract

The aim of the study was to prospectively investigate the efficacy of recombinant human follicle-stimulating hormone (rhFSH) in the treatment of various types of male-factor infertility at a single university hospital. The study included 61 infertile men receiving rhFSH because of various type of male infertility. Treatment included 100–150 IU of rhFSH 2–3 times/wk. All men were divided into 4 groups: hypogonadotropic hypogonadism (n = 21), isolated follicle-stimulating hormone (FSH) deficiency (n = 13), idiopathic oligoasthenospermia (n = 16) and maturation arrest on testicular biopsy (n = 11). Total motile sperm count (TMSC), serum FSH level, and testicular volume were compared before and after treatment in all groups. In the hypogonadotropic hypogonadism group, spermatozoa appeared in the ejaculate, with a mean TMSC of 6.67 ± 1.57 million, in 15 of 21 patients (71.4%) who were totally azoospermic before the treatment. In the isolated FSH deficiency group, TMSC significantly increased from 6.64 ± 3.27 to 32.4 ± 9.09 million after the treatment (P = .003). TMSC did not significantly increase in the idiopathic oligoasthenospermia group. Two of the men with maturation arrest (18.1%) had spermatozoa in the ejaculate after the treatment. rhFSH therapy may be effectively used to improve sperm parameters in infertile men with hypogonadotropic hypogonadism and isolated FSH deficiency. In addition, rhFSH may effect some improvement by either providing sperm in ejaculate or increasing intracytoplasmic sperm injection success in infertile men with maturation arrest.

     Key words: Male infertility, recombinant human FSH, sperm






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The American Society of Andrology.